Germana Castelli

Iss
Rome, 00161, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 88 publications

Acute Myeloid Leukemias with Alterations of Lysine Methyltransferase 2A (KMT2A): Recent Therapeutic Developments.

Acute Myeloid Leukemias with Alterations of Lysine Methyltransferase 2A (KMT2A): Recent Therapeutic Developments.

Journal: Cancers

Published: March 19, 2026

The Spectrum of Venetoclax-Based Treatments in Acute Myeloid Leukemia.

The Spectrum of Venetoclax-Based Treatments in Acute Myeloid Leukemia.

Journal: Cancers

Published: February 16, 2026

Curative Approach to the Treatment of Beta-Thalassemia and Sickle Cell Disease with Hematopoietic Stem Cell Transplantation.

Curative Approach to the Treatment of Beta-Thalassemia and Sickle Cell Disease with Hematopoietic Stem Cell Transplantation.

Journal: Journal of clinical medicine

Published: December 29, 2025

Gene Therapy of Beta Hemoglobinopathies.

Gene Therapy of Beta Hemoglobinopathies.

Journal: Biomedicines

Published: November 06, 2025

Clinical and Biological Insights into Myelodysplastic Neoplasms Associated with Deletions of Chromosome 5q Region.

Clinical and Biological Insights into Myelodysplastic Neoplasms Associated with Deletions of Chromosome 5q Region.

Journal: Hematology reports

Published: October 06, 2025

CFTR Modulator Response in Nasal Organoids Derived from People with Cystic Fibrosis.

CFTR Modulator Response in Nasal Organoids Derived from People with Cystic Fibrosis.

Journal: Cells

Published: October 02, 2025

Outline of Iron Metabolism, with Emphasis on Erythroid Cells.

Outline of Iron Metabolism, with Emphasis on Erythroid Cells.

Journal: Mediterranean journal of hematology and infectious diseases

Published: July 19, 2025

Emerging Role of Chimeric Antigen Receptor-Natural Killer Cells for the Treatment of Hematologic Malignancies.

Emerging Role of Chimeric Antigen Receptor-Natural Killer Cells for the Treatment of Hematologic Malignancies.

Journal: Cancers

Published: March 21, 2025

PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias.

PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias.

Journal: Leukemia

Published: March 21, 2025

Toxicities Associated with CAR-T Cell Therapies.

Toxicities Associated with CAR-T Cell Therapies.

Journal: Mediterranean journal of hematology and infectious diseases

Published: March 05, 2025

Recent Developments in Differentiation Therapy of Acute Myeloid Leukemia.

Recent Developments in Differentiation Therapy of Acute Myeloid Leukemia.

Journal: Cancers

Published: February 07, 2025

Braf-Mutant Melanomas: Biology and Therapy.

Braf-Mutant Melanomas: Biology and Therapy.

Journal: Current oncology (Toronto, Ont.)

Published: October 28, 2024

Showing 1-12 of 88

Last Updated: 09/26/2026